Prosecution Insights
Last updated: April 19, 2026

Foley Hoag, LLP (General)

230 pending office actions • 146 clients

Portfolio Summary

230
Total Pending OAs
60
Final Rejections
170
Non-Final OAs

Client Portfolio (146 clients)

Client (Assignee)Pending OAs
Enza Zaden Beheer B.V. 15
Inscripta, Inc. 8
Amazentis SA 7
Evelo Biosciences, Inc. 7
The General Hospital Corporation 5
Punchh Inc. 4
Linus Health, Inc. 4
Lenbrook Industries Limited 3
VASCUTEK LIMITED 3
Technische Universität München 3
Discgenics, Inc. 3
Bolton Medical, Inc. 3
BAYER AKTIENGESELLSCHAFT 3
The University of Birmingham 3
Tpi Technology, Inc. 2
UCHU Biosensors, Inc. 2
The Regents of the University of Colorado 2
Quantum-Si Incorporated 2
Flux Marine Ltd. 2
National University Of Singapore 2
Cognosos, Inc. 2
ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE 2
Revelation Biosciences, Inc. 2
Flagship Labs 114, Inc. 2
Centro De Inmunología Molecular 2
The Trustees of Dartmouth College 2
Metro International Biotech, LLC 2
Intocell, Inc. 2
Ahs Hospital Corp. 2
Navtrix Pty Ltd. 2
C4X Discovery Limited 2
The Regents of the University of Colorado 2
Leap Therapeutics, Inc. 2
UNS IP HOLDINGS, LLC 2
Simsi, Inc. 1
Arkea Bio Corp. 1
Spinthyr Technologies, LLC 1
Armr Systems, Inc. 1
Tpi Composites, Inc. 1
Connectwise, LLC 1
Linus Health, Inc. 1
Matinas Biopharma Nanotechnologies, Inc. 1
Enzazaden Beheer B.V. 1
Anji Pharmaceuticals Inc. 1
Arthur Shulkes 1
Verté Therapeutics, LLC 1
The Board Of Trustees Of The University Of Illinois 1
Backbar Solutions 1
Neophore Limited 1
Caretech Human Inc. 1
BEIJING INNOCARE PHARMA TECH CO., LTD. 1
The Regents of the University of California 1
Karyopharm Therapeutics Inc. 1
Imaginatives Group Limited 1
Aurigene Discovery Technologies Limited 1
Nutrition21, LLC 1
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. 1
Lawell Therapeutics, LLC 1
Kneevoice, Inc. 1
Intellia Therapeutics, Inc. 1
Intellia Therapeutics, Inc. 1
Oncocube Therapeutics LLC 1
Chong Kun Dang Pharmaceutical Corp. 1
Sloan-Kettering Institute For Cancer Research 1
Stealth BioTherapeutics Inc. 1
Inflammasome Therapeutics, Inc. 1
Prime Medicine, Inc. 1
American River Nutrition, LLC 1
Aviko Radiopharmaceuticals, LLC 1
Celleron Therapeutics Limited 1
ToDx Inc. 1
Brenus Pharma 1
Ligachem Biosciences, Inc. 1
Cellino Biotech, Inc. 1
Proabtech Co., Ltd. 1
Vandria SA 1
The University of Manchester 1
The University of Liverpool 1
Odyssey Therapeutics UK Limited 1
Tabomedex Biosciences, Inc. 1
Repair Biotechnologies, Inc. 1
The Brigham And Women'S Hospital, Inc. 1
Cornell University 1
Aurigene Discovery Technologies Limited 1
Jnana Therapeutics Inc. 1
Paradigm Biopharmaceuticals Ltd. 1
Zbiotics Company 1
University of Limpopo 1
Aoa Dx 1
Universidad de la Habana 1
Hai Kang Life Corporation Limited 1
Storm Therapeutics Limited 1
BMG Incorporated 1
Evelo Biosciences, Inc. 1
Purinomia Biotech, Inc. 1
Massachusetts Institute Of Technology 1
UNIVERSITY OF OXFORD 1
University of Huddersfield 1
Ecolectro, Inc. 1
Antirna Incorporated 1
Rf Labs, Inc. 1
Ipex Usa LLC 1
DANA-FARBER CANCER INSTITUTE, INC. 1
Commonwealth Scientific And Industrial Research Organisation 1
The University Court of the University of Edinburgh 1
Tscan Therapeutics, Inc. 1
Stealth BioTherapeutics Inc. 1
Anaxis Pharma Pty Ltd 1
BAYER AKTIENGESELLSCHAFT 1
The Broad Institute, Inc. 1
Genofocus, Inc. 1
Roslin Technologies Limited 1
Real Isolates, LLC 1
Proteinea, Inc. 1
Yuyu Pharma, Inc. 1
United Biomedical, Inc. 1
Spareit, Inc. 1
BEIJING INNOCARE PHARMA TECH CO., LTD. 1
Technische Universitat Munchen 1
Macquarie University 1
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 1
Quantum Diamond Technologies Inc. 1
Gnt Pharma Co., Ltd. 1
Medizinische Hochschule Hannover 1
Dionis Therapeutics, Inc. 1
Biocryst Pharmaceuticals, Inc. 1
Biocryst Pharmaceuticals, Inc. 1
Michael S. Clemmons 1
Seracare Life Sciences, Inc. 1
Y-Biologics, Inc. 1
The Regents of the University of California 1
Crt Pioneer Fund LP 1
Prevep, Inc. 1
2Seventy Bio, Inc. 1
Advantage Therapeutics, Inc. 1
Sapphiros Al Bio LLC 1
Boyce Thompson Institute For Plant Research 1
VASCUTEK LIMITED 1
Ada Forsyth Institute, Inc. 1
Williwaw Biosciences LLC 1
BIOSCEPTRE (AUST) PTY LTD 1
The Regents of the University of Colorado 1
Orig3N, Inc. 1
Atara Biotherapeutics, Inc. 1
Windgap Medical, Inc. 1
Nanotics, LLC 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19288554 Untitled Lenbrook Industries Limited SAUNDERS JR, JOSEPH 2692 Non-Final OA
19311619 ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS Amazentis SA VALENROD, YEVGENY 1628 Non-Final OA Aug 27, 2025
19170782 ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS Amazentis SA VALENROD, YEVGENY 1628 Non-Final OA Apr 04, 2025
19170838 METHODS FOR AUTOMATING THE PROMPTING AND POST-PROCESSING OF AI SYSTEMS FOR INTERPRETATION AND REPORTING OF PUBLIC SAFETY DATA, STATISTICS, AND CONTEXTUAL KNOWLEDGE Simsi, Inc. PADUA, NICO LAUREN 3626 Non-Final OA Apr 04, 2025
19069880 IDENTIFICATION AND CALCULATION OF FINANCIAL LOSS FROM ODOMETER FRAUD Unknown KYU, TAYAR M 3628 Non-Final OA Mar 04, 2025
19049535 POWER OVER ETHERNET (PoE) POWERED SMART SPEAKER Lenbrook Industries Limited PAUL, DISLER 2695 Final Rejection Feb 10, 2025
19028700 ROOT INSERT STOPPER FASTENING EQUIPMENT Tpi Technology, Inc. COOK, KYLE A 3726 Non-Final OA Jan 17, 2025
19016420 VACCINES COMPRISING PROTEINS AND/OR PEPTIDES OF METHANOBREVIBACTER GOTTSCHALKII Arkea Bio Corp. FOLEY, SHANON A 1671 Non-Final OA Jan 10, 2025
18987408 HYBRID TOMATO VARIETIES 'E15A43013', 'E15B43148', ‘E15B43155’, AND ‘E15C42988’ Enza Zaden Beheer B.V. PAGE, BRENT T 1663 Non-Final OA Dec 19, 2024
18947815 INVERTED SURGICAL RETRACTOR DEVICE Unknown JOHANAS, JACQUELINE T 3773 Final Rejection Nov 14, 2024
18861976 CHEST BOLT AND THORACOSTOMY BOLT Spinthyr Technologies, LLC LONG, SARAH A 3771 Non-Final OA Oct 31, 2024
18926860 STENT DEVICE VASCUTEK LIMITED RIVERS, LINDSEY RAE 3771 Non-Final OA Oct 25, 2024
18905355 HYBRID TOMATO VARIETIES 'E15A43014', 'E15B42750', AND 'E15M43066' Enza Zaden Beheer B.V. SHARMA, SANTOSH 1663 Non-Final OA Oct 03, 2024
18886527 HYBRID TOMATO VARIETIES 'E15T43109' AND 'E15T43110' Enza Zaden Beheer B.V. KUMAR, VINOD 1663 Non-Final OA Sep 16, 2024
18843876 INTRAORAL MONITOR AND METHODS OF MANUFACTURE UCHU Biosensors, Inc. WRIGHT, ALEXANDER SCOTT 1745 Non-Final OA Sep 04, 2024
18821532 PRESSURE APPLICATION SYSTEM Armr Systems, Inc. KHANDKER, RAIHAN R 3771 Non-Final OA Aug 30, 2024
18842526 SPINACH PLANT RESISTANT TO DOWNY MILDEW AND NOVEL RESISTANCE GENE Enza Zaden Beheer B.V. ORDAZ, CHRISTIAN JOSE 1663 Non-Final OA Aug 29, 2024
18805772 SPATIAL COORDINATE TRACKING OF WIND TURBINE ASSEMBLY COMPONENTS USING LASER PROJECTION SYSTEM Tpi Composites, Inc. SONG, INJA 1744 Non-Final OA Aug 15, 2024
18792939 GENERALIZED ENTERPRISE CATALOG CLASSIFICATION FOR SHORTHAND ITEMDESCRIPTORS Punchh Inc. FRUNZI, VICTORIA E. 3689 Non-Final OA Aug 02, 2024
18790846 CREATING AN INTEGRATION AT A VENDOR LAYER Connectwise, LLC GURMU, MULUEMEBET 2163 Non-Final OA Jul 31, 2024
18784462 DEVICES FOR IMPLANTATION OF CELLULAR TRANSPLANTS AND METHODS OF USING THE SAME The Regents of the University of Colorado MULLINS, JESSICA LYNN 3792 Non-Final OA Jul 25, 2024
18783046 LETTUCE VARIETY 'SUNBERG’ Enza Zaden Beheer B.V. ZHONG, WAYNESHAOBIN 1662 Non-Final OA Jul 24, 2024
18778356 LETTUCE VARIETY 'E01G11679' Enza Zaden Beheer B.V. BYRNES, DAVID R 1662 Non-Final OA Jul 19, 2024
18774469 METHOD FOR DETECTING IMPAIRMENT STATUS ON INSTRUMENTAL ACTIVITIES OF DAILY LIVING Linus Health, Inc. LANE, DANIEL E 3715 Final Rejection Jul 16, 2024
18768458 SYSTEMS AND METHODS FOR PREDICTING PET AMYLOID BIOMARKER STATUS USING MULTIMODAL DIGITAL COGNITIVE ASSESSMENTS Linus Health, Inc. LANE, DANIEL E 3715 Final Rejection Jul 10, 2024
18767226 ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS Matinas Biopharma Nanotechnologies, Inc. DAVIS, BRIAN J 1614 Non-Final OA Jul 09, 2024
18722389 LETTUCE PLANT RESISTANT TO DOWNY MILDEW AND RESISTANCE GENE Enzazaden Beheer B.V. ORDAZ, CHRISTIAN JOSE 1663 Non-Final OA Jun 20, 2024
18670099 PERISTALTIC PUMPING OF FLUIDS AND ASSOCIATED METHODS, SYSTEMS, AND DEVICES Quantum-Si Incorporated KASTURE, DNYANESH G 3746 Non-Final OA May 21, 2024
18668709 COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS Anji Pharmaceuticals Inc. PROSSER, ALISSA J 1619 Non-Final OA May 20, 2024
18654512 LETTUCE VARIETIES ‘E01C11866’, ‘E01L30616’ AND ‘E01B11959’ Enza Zaden Beheer B.V. DEVEAU ROSEN, JASON 1662 Non-Final OA May 03, 2024
18647916 PREDICTIVE RFM SEGMENTATION Punchh Inc. EL-HAGE HASSAN, ABDALLAH A 3623 Final Rejection Apr 26, 2024
18648010 SPRAY APPLICATION OF WATER SOLUBLE ACTIVES TO DRINKING VESSELS AND OTHER OBJECTS Unknown FUBARA, BLESSING M 1613 Non-Final OA Apr 26, 2024
18634105 MODULAR, REPLACEABLE OUTBOARD FAIRINGS FOR APPLICATION SPECIFIC OPTIMIZATION Flux Marine Ltd. VASUDEVA, AJAY 3615 Non-Final OA Apr 12, 2024
18634264 MODULAR BELT TENSIONING MECHANISM AND POWERHEAD STRUCTURE OF A MARINE PROPULSION SYSTEM Flux Marine Ltd. MISIASZEK, AMBER ALTSCHUL 3682 Non-Final OA Apr 12, 2024
18627964 SYSTEMS AND METHODS FOR MOBILE SPEECH HEARING OPTIMIZATION Linus Health, Inc. ROBERTS, ANNA L 3791 Non-Final OA Apr 05, 2024
18616477 METHODS AND COMPOSITIONS FOR INHIBITING A NOXIOUS INSULT Arthur Shulkes CRAIGO, WILLIAM A 1615 Non-Final OA Mar 26, 2024
18692691 METHODS OF FABRICATING CURVED TWO-DIMENSIONAL MEMBRANES AND MEMBRANES THEREOF National University Of Singapore FLORES JR, DONALD M 1781 Non-Final OA Mar 15, 2024
18603163 POLYMERIZING ENZYMES FOR SEQUENCING REACTIONS Quantum-Si Incorporated EPSTEIN, TODD MATTHEW 1652 Non-Final OA Mar 12, 2024
18690537 POLYSACCHARIDE OR POLYSACCHARIDE MIXTURE PRODUCED BY PAENIBACILLUS POLYMYXA Technische Universität München LANKFORD JR, LEON B 1657 Non-Final OA Mar 08, 2024
18596170 TECHNIQUES FOR REAL-TIME RESPONSE STRATEGIES IN A SUPPLY CHAIN Cognosos, Inc. EL-BATHY, IBRAHIM N 3628 Non-Final OA Mar 05, 2024
18687108 TREATING LONG COVID-19 WITH UROLITHINS Amazentis SA CORNET, JEAN P 1628 Non-Final OA Feb 27, 2024
18685686 GENOME-WIDE RATIONALLY-DESIGNED MUTATIONS LEADING TO ENHANCED CELLOBIOHYDROLASE I PRODUCTION IN S. CEREVISIAE Inscripta, Inc. MCKNIGHT, CIARA A 1656 Non-Final OA Feb 22, 2024
18682544 WOUND MONITORING SYSTEM AND SENSOR THEREOF National University Of Singapore WESTFALL, SARAH ANN 3791 Non-Final OA Feb 09, 2024
18436462 HYBRID TOMATO VARIETY 'E15M43069', 'E15T43094' and 'E15T43096' Enza Zaden Beheer B.V. BUI, PHUONG T 1663 Non-Final OA Feb 08, 2024
18431448 PARAMETRIC AND AUTOMATED TOOL FOR THE DESIGN OF STEEL SUBSTRUCTURE OF COMPOSITE MOLDS Tpi Technology, Inc. ARTHUR JEANGLAUDE, GERTRUDE 3661 Non-Final OA Feb 02, 2024
18427141 RESISTANCE GENE AND LETTUCE PLANT RESISTANT TO DOWNY MILDEW Enza Zaden Beheer B.V. BYRNES, DAVID R 1662 Non-Final OA Jan 30, 2024
18424380 VETERINARY TRANSDERMAL GEL COMPRISING ONDANSETRON, AND RELATED METHODS Verté Therapeutics, LLC HUI, SAN MING R 1627 Non-Final OA Jan 26, 2024
18292036 DRUG DELIVERY PLATFORM FOR DELIVERY OF THERAPEUTICS AND METHODS OF USE AND MANUFACTURE THEREOF Unknown PIPIC, ALMA 1617 Non-Final OA Jan 25, 2024
18417731 COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION AND TREATING NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS Amazentis SA CHEN, CATHERYNE 1655 Non-Final OA Jan 19, 2024
18416244 ISOLATED DISCOGENIC CELLS, METHODS OF USING, AND METHODS OF PREPARING SAME FROM MAMMALIAN TISSUE Discgenics, Inc. PAPCIAK, SHARON M 1657 Final Rejection Jan 18, 2024
18405347 RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS The Board Of Trustees Of The University Of Illinois OLSON, ANDREA STEFFEL 1693 Non-Final OA Jan 05, 2024
18576696 COMPOSITIONS AND METHODS FOR DECREASING PIGMENTATION The General Hospital Corporation GREENE, IVAN A 1619 Non-Final OA Jan 04, 2024
18575007 SYSTEM AND METHOD FOR CONTACTLESS DRINK DISPENSING Backbar Solutions PANCHOLI, VISHAL J 3754 Non-Final OA Dec 28, 2023
18573519 TETRACYCLINE DERIVATIVE-INDUCED MITOHORMESIS MEDIATES DISEASE TOLERANCE AGAINST VIRAL INFECTIONS ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE SHAMEEM, GOLAM M 1621 Non-Final OA Dec 22, 2023
18570244 INHIBITOR COMPOUNDS Neophore Limited NESTOR, DONNA MICHELLE 1627 Non-Final OA Dec 14, 2023
18538877 IDENTIFICATION OF A PERSON BY THE UNIQUE CHEMICAL COMPOSITION OF A BIOMATERIAL IN DIFFERENT PHASES Caretech Human Inc. ABOUELELA, MAY A 3791 Non-Final OA Dec 13, 2023
18568771 HETEROCYCLIC JAK INHIBITOR BEIJING INNOCARE PHARMA TECH CO., LTD. YOO, SUN JAE 1621 Non-Final OA Dec 08, 2023
18532671 TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN The Regents of the University of California WARD, PAUL V 1622 Non-Final OA Dec 07, 2023
18526900 NUCLEAR TRANSPORT MODULATORS AND USES THEREOF Karyopharm Therapeutics Inc. RODRIGUEZ-GARCIA, VALERIE 1621 Non-Final OA Dec 01, 2023
18565721 MINERALOCORTICOID RECEPTOR ANTAGONISTS FOR THE PREVENTION AND/OR TREATMENT OF A CORONAVIRUS INFECTION Imaginatives Group Limited BARSKY, JARED 1628 Non-Final OA Nov 30, 2023
18564384 CANCER THERAPY USING A COMBINATION OF CDK7 INHIBITOR WITH AN ANTI-CANCER AGENT Aurigene Discovery Technologies Limited ROMERO, KRISTEN WANG 1624 Non-Final OA Nov 27, 2023
18562719 MPLA COMPOSITIONS AND METHODS OF USE Revelation Biosciences, Inc. TIEN, LUCY MINYU 1612 Non-Final OA Nov 20, 2023
18562696 METHODS OF TREATING OR PREVENTING ALLERGIES AND CHRONIC NASAL CONGESTION Revelation Biosciences, Inc. KRISHNAN, GANAPATHY 1693 Non-Final OA Nov 20, 2023
18511413 CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS Nutrition21, LLC CHEN, CATHERYNE 1655 Non-Final OA Nov 16, 2023
18503569 AORTIC PROSTHESIS DELIVERY DEVICE AND METHOD OF USE Bolton Medical, Inc. BARIA, DINAH N 3774 Non-Final OA Nov 07, 2023
18558165 SALT CONTAINING PIPERAZINE POLYCYCLIC DERIVATIVE, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. RAO, SAVITHA M 1691 Non-Final OA Oct 30, 2023
18287784 METHODS OF PREPARING AN EXTRACORPOREAL CIRCUIT FOR ANTICOAGULATION Lawell Therapeutics, LLC DEAK, LESLIE R 3799 Non-Final OA Oct 20, 2023
18491049 DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING Inscripta, Inc. MONTANARI, DAVID A 1632 Non-Final OA Oct 20, 2023
18556563 TISSUE-SPECIFIC NUCLEIC ACID DELIVERY BY MIXED CATIONIC LIPID PARTICLES Flagship Labs 114, Inc. TATGE, LEXUS MARC 1637 Non-Final OA Oct 20, 2023
18381910 ASSESSING JOINT CONDITION USING ACOUSTIC SENSORS Kneevoice, Inc. FERNANDES, PATRICK M 3791 Non-Final OA Oct 19, 2023
18287227 INHIBITORS OF DNA-DEPENDENT PROTEIN KINASE AND COMPOSITIONS AND USES THEREOF Intellia Therapeutics, Inc. HEASLEY, MEGHAN CHRISTINE 1626 Non-Final OA Oct 17, 2023
18287229 LIPID NANOPARTICLES COMPOSITIONS Intellia Therapeutics, Inc. JOHNSON, CHRISTOPHER LINDSAY 1691 Non-Final OA Oct 17, 2023
18286469 COMPOSITIONS AND METHODS FOR TREATING CANCER Oncocube Therapeutics LLC VALLE, ERNESTO 1623 Non-Final OA Oct 11, 2023
18286037 1,3,4-OXADIAZOLE THIOCARBONYL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. ENGLISH, CONNOR KENNEDY 1625 Non-Final OA Oct 06, 2023
18285925 NADK2 INHIBITION IN CANCER AND FIBROTIC DISORDERS Sloan-Kettering Institute For Cancer Research VAN BUREN, LAUREN K 1638 Non-Final OA Oct 06, 2023
18285890 PHARMACEUTICAL COMPOSITION CONTAINING BACTERIA Evelo Biosciences, Inc. JACKSON-TONGUE, LAKIA J 1645 Non-Final OA Oct 06, 2023
18285570 SILICA-BASED FORMULATIONS OF THERAPEUTIC OLIOGPEPTIDES AND PEPTIDOMIMETICS Stealth BioTherapeutics Inc. TIEN, LUCY MINYU 1612 Non-Final OA Oct 04, 2023
18375713 IMPLANT Inflammasome Therapeutics, Inc. KIM, DANIELLE A 1613 Non-Final OA Oct 02, 2023
18374983 HYBRID PEPPER VARIETY 'E20S0465' Enza Zaden Beheer B.V. FAN, WEIHUA 1663 Non-Final OA Sep 29, 2023
18478179 METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES Prime Medicine, Inc. MCKNIGHT, CIARA A 1656 Non-Final OA Sep 29, 2023
18374250 CONTEXTUAL AWARENESS FOR UNSUPERVISED ADMINISTRATION OF COGNITIVE ASSESSMENTS REMOTELY OR IN A CLINICAL SETTING Linus Health, Inc. WEBB, JESSICA MARIE 3683 Final Rejection Sep 28, 2023
18473740 ORAL CARE COMPOSITIONS COMPRISING GERANYLGERANIOL AND METHODS OF USE THEREOF American River Nutrition, LLC GEMBEH, SHIRLEY V 1615 Non-Final OA Sep 25, 2023
18370678 SMALL MOLECULES FOR BORON NEUTRON CAPTURE THERAPY Aviko Radiopharmaceuticals, LLC CHEN, PO-CHIH 1621 Non-Final OA Sep 20, 2023
18283158 VACCINE ADJUVANT Celleron Therapeutics Limited OH, TAYLOR V 1625 Non-Final OA Sep 20, 2023
18280849 PARALLEL DETECTION AND QUANTIFICATION OF NUCLEIC ACID BASED MARKERS ToDx Inc. GREENE, CAROLYN LEE 1681 Non-Final OA Sep 07, 2023
18240550 METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING Inscripta, Inc. BRETZ, COREY LANE 1635 Non-Final OA Aug 31, 2023
18455221 CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS Inscripta, Inc. KANE, TREVOR LOGAN 1657 Non-Final OA Aug 24, 2023
18547760 NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS Brenus Pharma MARTIN, PAUL C 1653 Non-Final OA Aug 24, 2023
18236571 HYBRID TOMATO VARIETY E15M42963 Enza Zaden Beheer B.V. BUI, PHUONG T 1663 Final Rejection Aug 22, 2023
18234732 COMPOUNDS COMPRISING SELF-IMMOLATIVE GROUP Ligachem Biosciences, Inc. DIAMOND, ALAN D 3991 Non-Final OA Aug 16, 2023
18234345 SYSTEMS AND METHODS FOR CELL MANUFACTURING Cellino Biotech, Inc. EDWARDS, LYDIA E 1796 Non-Final OA Aug 15, 2023
18274670 MULTIMERIC PROTEIN-ALBUMIN CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF Proabtech Co., Ltd. MEAH, MOHAMMAD Y 1652 Non-Final OA Jul 27, 2023
18359382 MODULATING CELLULAR REPAIR MECHANISMS FOR GENOMIC EDITING Inscripta, Inc. WARD, AARON DUREL 1636 Non-Final OA Jul 26, 2023
18226590 UROLITHIN DERIVATIVES AND THERAPEUTIC USES Vandria SA DROUIN, STEVE HOANG 1627 Non-Final OA Jul 26, 2023
17926847 ANTIVIRAL POLYMERS The University of Manchester PIPIC, ALMA 1617 Non-Final OA Jul 19, 2023
18223833 HYBRID TOMATO VARIETIES 'E15A51293' AND 'E15A51296' Enza Zaden Beheer B.V. DEVEAU ROSEN, JASON 1662 Final Rejection Jul 19, 2023
18272697 AZAQUINAZOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING DIROFILARIA INFECTION IN A MAMMAL The University of Liverpool RAO, PADMAJA S 1627 Non-Final OA Jul 17, 2023
18271918 QUANTUM COMPUTING SYSTEM AND METHOD Odyssey Therapeutics UK Limited GOODCHILD, WILLIAM J 2433 Non-Final OA Jul 12, 2023
18271503 PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE PAULUS, ERIN VIRGINIA 1631 Non-Final OA Jul 10, 2023
18348128 MAD NUCLEASES Inscripta, Inc. REGLAS, GEORGIANA C 1651 Non-Final OA Jul 06, 2023
18270616 FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF Tabomedex Biosciences, Inc. VISHNYAKOVA, ELENA VLADIMIROVNA 1691 Non-Final OA Jun 30, 2023
18269869 HEPATOCELLULAR CARCINOMA TREATMENTS, PROPHYLACTIC THERAPIES, AND COMPOSITIONS FOR USE THEREWITH Repair Biotechnologies, Inc. IANNUZO, NATALIE NMN 1653 Non-Final OA Jun 27, 2023
18269168 COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS The Brigham And Women'S Hospital, Inc. OH, TAYLOR V 1625 Non-Final OA Jun 22, 2023
18210992 MACROPHAGES/MICROGLIA IN NEURO-INFLAMMATION ASSOCIATED WITH NEURODEGENERATIVE DISEASES The General Hospital Corporation MCANANY, JOHN D 1625 Final Rejection Jun 16, 2023
18268102 METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND STAT3-LINKED CANCERS USING SUPPRESSORS OF ELECTRON LEAK Cornell University MARTIN, KEVIN STEPHEN 1624 Non-Final OA Jun 16, 2023
18257962 COCRYSTAL OF A CDK INHIBITOR Aurigene Discovery Technologies Limited LEE, CHIHYI NMN 1628 Non-Final OA Jun 16, 2023
17769173 REACTIVE AFFINITY PROBE-INTERACTION DISCOVERY PLATFORM Jnana Therapeutics Inc. DAUNER, JOSEPH G 1682 Non-Final OA Jun 15, 2023
18266486 USE OF VACCINE COMPOSITIONS BASED ON SARS-COV-2 RECEPTOR BINDING DOMAIN IN DELIVERING PROTECTIVE IMMUNITY Centro De Inmunología Molecular CHEN, STACY BROWN 1672 Non-Final OA Jun 09, 2023
18206368 LETTUCE VARIETIES 'EZFLOR', 'BAUER', AND 'ADICAMP' Enza Zaden Beheer B.V. FAN, WEIHUA 1663 Final Rejection Jun 06, 2023
18255906 TISSUE-SPECIFIC NUCLEIC ACID DELIVERY BY 1,2-DIOLEOYL-3-TRIMETHYLAMMONIUM-PROPANE (DOTAP) LIPID NANOPARTICLES Flagship Labs 114, Inc. DACE DENITO, ALEXANDRA GERALDINE 1636 Non-Final OA Jun 05, 2023
18205305 ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS Amazentis SA VALENROD, YEVGENY 1628 Non-Final OA Jun 02, 2023
18204492 TREATMENT OF POST-OPERATIVE JOINT PAIN WITH POLYSULFATED POLYSACCHARIDES Paradigm Biopharmaceuticals Ltd. CHO, DAVID H 1693 Final Rejection Jun 01, 2023
18202182 METHODS AND COMPOSITION FOR TREATING METABOLIC SYNDROME Zbiotics Company PRAKASH, SUBBALAKSHMI 1793 Final Rejection May 25, 2023
18254120 METHODS AND SYSTEMS FOR TREATMENT OF INTERVERTEBRAL DISC BY INTRADISCAL MICRO-NEEDLE INSERTION Discgenics, Inc. BOSWORTH, KAMI A 3783 Non-Final OA May 23, 2023
18038378 APPARATUS AND METHOD FOR SANITISING OBJECTS Unknown JEONG, YOUNGSUL 1772 Final Rejection May 23, 2023
18037669 PRODUCTION OF ALKALI METAL CARBONATES AND/OR BICARBONATES FROM ALKALI METAL SULPHATES University of Limpopo SIMKINS, SLONE ELIZABETH 1735 Final Rejection May 18, 2023
18196536 HYBRID TOMATO VARIETIES 'E15C42785' AND 'E15C42788' Enza Zaden Beheer B.V. BUI, PHUONG T 1663 Final Rejection May 12, 2023
18035399 VISTA AGONIST FOR TREATMENT/PREVENTION OF ISCHEMIC AND/OR REPERFUSION INJURY The Trustees of Dartmouth College SULLIVAN, DENNIS JOHN 1642 Non-Final OA May 04, 2023
18309141 MICROCAPILLARY DEVICE, DETECTION DEVICE, AND METHODS RELATED THERETO Unknown SUN, CAITLYN MINGYUN 1795 Final Rejection Apr 28, 2023
18034202 COMPOSITIONS COMPRISING SPIRULINA COMPONENTS Evelo Biosciences, Inc. ARIANI, KADE 1651 Non-Final OA Apr 27, 2023
18032096 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BAYER AKTIENGESELLSCHAFT HIRAKIS, SOPHIA P 1623 Non-Final OA Apr 14, 2023
18032067 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BAYER AKTIENGESELLSCHAFT HIRAKIS, SOPHIA P 1623 Non-Final OA Apr 14, 2023
18132073 HYBRID PEPPER 'E20S.10382' Enza Zaden Beheer B.V. BUI, PHUONG T 1663 Final Rejection Apr 07, 2023
18030426 COMPOSITIONS AND METHODS FOR CANCER DIAGNOSIS Aoa Dx STOICA, ELLY GERALD 1647 Non-Final OA Apr 05, 2023
18029766 COVALENT CONJUGATES OF THE SARS-COV-2 RECEPTOR-BINDING DOMAIN AND A CARRIER PROTEIN AND VACCINE COMPOSITIONS THAT CONTAIN THEM Universidad de la Habana GILL, RACHEL B 1671 Non-Final OA Mar 31, 2023
18192425 WIRELESS HIGH-RESOLUTION HEADPHONES Lenbrook Industries Limited SNIEZEK, ANDREW L 2693 Final Rejection Mar 29, 2023
18127887 IMAGE QUANTIFICATION SYSTEM FOR ESTIMATION OF VIRAL LOAD BASED ON DETECTION BY RAPID ANTIGEN TEST Hai Kang Life Corporation Limited DUNN, MCKENZIE A 1678 Non-Final OA Mar 29, 2023
18028286 METTL3 INHIBITORY COMPOUNDS Storm Therapeutics Limited MARTIN, KEVIN STEPHEN 1624 Non-Final OA Mar 24, 2023
18028393 ANTIMICROBIAL FACEMASK BMG Incorporated SINGH-PANDEY, ARTI R 1759 Non-Final OA Mar 24, 2023
18027003 SOLID DOSAGE FORMS OF BACTERIA Evelo Biosciences, Inc. JACKSON-TONGUE, LAKIA J 1645 Non-Final OA Mar 17, 2023
18025072 METHODS AND COMPOSITIONS FOR POTENTIATING ANTITUMORAL IMMUNE RESPONSES THROUGH TARGETING OF NTPDASE3 Purinomia Biotech, Inc. WEIDNER, ADAM M 1675 Non-Final OA Mar 07, 2023
18116662 ALTERNATING MULTI-SOURCE VAPOR TRANSPORT DEPOSITION Massachusetts Institute Of Technology LOUIE, MANDY C 1718 Final Rejection Mar 02, 2023
18114092 USES OF UROLITHINS Amazentis SA GANGLE, BRIAN J 1645 Non-Final OA Feb 24, 2023
18021731 COMPOSITIONS OF SARS-COV-2 VACCINES BASED ON THE RECEPTOR BINDING DOMAIN, EXPRESSED AS A DIMER, AND THE OUTER MEMBRANE VESICLE OF MENINGOCOCCAL GROUP B BACTERIA Centro De Inmunología Molecular CHEN, STACY BROWN 1672 Non-Final OA Feb 16, 2023
18021508 LMO2 PROTEIN INHIBITORS UNIVERSITY OF OXFORD KIFLE, BRUCK 1624 Non-Final OA Feb 15, 2023
18168340 VASCULAR PROSTHESES, DELIVERY SYSTEMS, AND METHODS TO TREAT AORTIC ANEURYSMS AND DISSECTIONS VASCUTEK LIMITED LOPEZ, LESLIE ANN 3774 Non-Final OA Feb 13, 2023
18020790 NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF University of Huddersfield HERNANDEZ, JACKSON J 1627 Non-Final OA Feb 10, 2023
18020473 POLYMER ELECTROLYTE COMPOSITES Ecolectro, Inc. KEELING, ALEXANDER W 1795 Final Rejection Feb 09, 2023
18166868 CURE ALL FOR NUCLEIC ACID-GUIDED CELL EDITING IN E. COLI Inscripta, Inc. RYAN, DOUGLAS CHARLES 1635 Non-Final OA Feb 09, 2023
18019940 COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION Antirna Incorporated MCMILLIAN, KARA RENITA 1623 Non-Final OA Feb 06, 2023
18103301 SYSTEMS AND METHODS FOR CARD GAME DATA PROCESSING Rf Labs, Inc. D'AGOSTINO, PAUL ANTHONY 3715 Final Rejection Jan 30, 2023
18007189 FIRE PROTECTION SYSTEM PIPE FITTINGS Ipex Usa LLC LINFORD, JAMES ALBERT 3679 Final Rejection Jan 27, 2023
18018207 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. MARTIN, KEVIN STEPHEN 1624 Non-Final OA Jan 26, 2023
18006072 SILICON-CONTAINING LIGAND COMPOUNDS Technische Universität München PACKARD, BENJAMIN J 1612 Non-Final OA Jan 19, 2023
18015906 NOVEL PEPTIDE TAG Technische Universität München MIKNIS, ZACHARY J 1658 Final Rejection Jan 12, 2023
18005145 PREVOTELLA HISTICOLA STRAIN C AS AN ORAL THERAPY FOR INFLAMMATORY DISEASES Evelo Biosciences, Inc. GANGLE, BRIAN J 1645 Non-Final OA Jan 11, 2023
18094643 AORTIC GRAFT ASSEMBLY Bolton Medical, Inc. RODJOM, KATHERINE MARIE 3771 Final Rejection Jan 09, 2023
18013455 TREATMENT OF COVID-19 AND/OR ACUTE KIDNEY INJURY Metro International Biotech, LLC CHO, DAVID H 1693 Final Rejection Dec 28, 2022
18012815 HYDROGELS Commonwealth Scientific And Industrial Research Organisation STEINKE, SEAN JAMES 1619 Non-Final OA Dec 23, 2022
18003021 TRANSGENE EXPRESSION SYSTEM The University Court of the University of Edinburgh ALLEN, SARAH ELIZABETH 1637 Final Rejection Dec 22, 2022
18084739 ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF Intocell, Inc. STONEBRAKER, ALYSSA RAE 1642 Non-Final OA Dec 20, 2022
18011577 COMPOSITIONS AND METHODS FOR IDENTIFYING EPITOPES Tscan Therapeutics, Inc. AMICK, THOMAS RUSSE 1638 Non-Final OA Dec 20, 2022
18011354 PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES Stealth BioTherapeutics Inc. KATAKAM, SUDHAKAR 1658 Non-Final OA Dec 19, 2022
18011408 AMIDO COMPOUNDS Anaxis Pharma Pty Ltd JACKSON, SHAWQUIA 1626 Non-Final OA Dec 19, 2022
18066581 VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER The Trustees of Dartmouth College OUSPENSKI, ILIA I 1644 Non-Final OA Dec 15, 2022
18081306 TUBULAR MEDICAL DEVICE VASCUTEK LIMITED PRESTON, REBECCA STRASZHEIM 3774 Non-Final OA Dec 14, 2022
18009900 CRISPR-CAS12A DIRECTED RANDOM MUTAGENESIS AGENTS AND METHODS BAYER AKTIENGESELLSCHAFT BOESEN, CHRISTIAN C 1684 Non-Final OA Dec 12, 2022
18009878 BINDING PROTEINS RECOGNIZING SARS-COV-2 ANTIGENS AND USES THEREOF Ahs Hospital Corp. VAN BUREN, LAUREN K 1638 Non-Final OA Dec 12, 2022
18009826 SARS-COV-2 IMMUNODOMINANT PEPTIDES AND USES THEREOF Ahs Hospital Corp. FORD, VANESSA L 1674 Non-Final OA Dec 12, 2022
18009566 POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS The University of Birmingham SHIAO, YIH-HORNG 1691 Non-Final OA Dec 09, 2022
18009485 FLUID GEL COMPOSITIONS The University of Birmingham FAN, LYNN Y 1759 Non-Final OA Dec 09, 2022
18009144 FLUID GEL COMPOSITIONS The University of Birmingham FAN, LYNN Y 1759 Non-Final OA Dec 08, 2022
18007822 METHODS OF TREATING A CORONAVIRUS INFECTION The General Hospital Corporation JOHNSON, CHRISTOPHER LINDSAY 1691 Final Rejection Dec 02, 2022
17927112 NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES The Broad Institute, Inc. LAFAVE, ELIZABETH ROSE 1684 Non-Final OA Nov 22, 2022
17987511 DYNAMIC ASSET TRACKING VIA LOW-ENERGY RADIO FREQUENCY DEVICES Cognosos, Inc. BILODEAU, DAVID 2648 Non-Final OA Nov 15, 2022
17923296 COMPOSITIONS COMPRISING ENZYMES AND PROBIOTICS, AND METHODS FOR PREVENTING OR TREATING MACULAR DEGENERATION Genofocus, Inc. PAGUIO FRISING, MICHELLE F 1651 Final Rejection Nov 04, 2022
18049832 VENDING MACHINE SYSTEM Navtrix Pty Ltd. SHAPIRO, JEFFREY ALAN 3619 Non-Final OA Oct 26, 2022
18049812 VENDING MACHINE SYSTEM Navtrix Pty Ltd. CHAMPAGNE, LUNA 3627 Final Rejection Oct 26, 2022
17920244 TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS C4X Discovery Limited ENGLISH, CONNOR KENNEDY 1625 Non-Final OA Oct 20, 2022
17920226 TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS C4X Discovery Limited JOHNSON, CHRISTOPHER LINDSAY 1691 Non-Final OA Oct 20, 2022
17995969 iPSC INDUCTION Roslin Technologies Limited MCCORMICK, CATHERINE LYNN 1638 Final Rejection Oct 11, 2022
17936708 COMPUTATIONAL APPROACHES TO ASSESSING CENTRAL NERVOUS SYSTEM FUNCTIONALITY USING A DIGITAL TABLET AND STYLUS Linus Health, Inc. GRANT, MICHAEL CHRISTOPHER 3715 Final Rejection Sep 29, 2022
17947312 METHODS FOR OBTAINING COMPOUNDS FROM A PLANT OR FUNGUS MATERIAL, RESPECTIVE COMPOSITIONS, AND USES THEREOF Real Isolates, LLC CHANDRAKUMAR, NIZAL S 1625 Non-Final OA Sep 19, 2022
17946816 METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASE USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) The Regents of the University of Colorado COFFA, SERGIO 1658 Non-Final OA Sep 16, 2022
17911930 RECOMBINANT PROTEIN PRODUCTION IN INSECTS Proteinea, Inc. SHEN, WU CHENG WINSTON 1682 Final Rejection Sep 15, 2022
17908396 TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS Yuyu Pharma, Inc. KATAKAM, SUDHAKAR 1658 Non-Final OA Aug 31, 2022
17801055 DESIGNER PEPTIDES AND PROTEINS FOR THE DETECTION, PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE, 2019 (COVID-19) United Biomedical, Inc. KINSEY WHITE, NICOLE ERIN 1672 Non-Final OA Aug 19, 2022
17797663 PROPHYLACTIC USES OF ANNEXIN A2 The Regents of the University of Colorado KOMATSU, LI N 1658 Final Rejection Aug 04, 2022
17796236 DATA-DRIVEN WORKPLACE WASTE REDUCTION APPROACH INVOLVING LIVE IN-BUILDING WASTE TRACKING, LIVE DATA ANALYTICS AND EMPLOYEE ENGAGEMENT PROGRAMS Spareit, Inc. SUMMERS, KIERSTEN V 3626 Non-Final OA Jul 28, 2022
17815844 SYSTEMS FOR MEASURING PATIENT PHYSIOLOGIC PARAMETERS UCHU Biosensors, Inc. DOUGHERTY, SEAN PATRICK 3791 Non-Final OA Jul 28, 2022
17868151 SUPPORT RING FOR VASCULAR AORTIC REPAIR AND METHODS OF USE Bolton Medical, Inc. WOZNICKI, JACQUELINE 3774 Final Rejection Jul 19, 2022
17867257 HEART VALVE AND ENDOVASCULAR GRAFT COMPONENTS AND METHOD FOR DELIVERY Unknown PATEL, AREN 3774 Final Rejection Jul 18, 2022
17793571 PYRIMIDIN-4(3H)-ONE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL USE THEREOF BEIJING INNOCARE PHARMA TECH CO., LTD. MAHLUM, JONATHAN DAVIS 1625 Final Rejection Jul 18, 2022
17866034 PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY Technische Universitat Munchen PERREIRA, MELISSA JEAN 1618 Non-Final OA Jul 15, 2022
17791770 STIMULATION OF HAIR GROWTH The General Hospital Corporation JOHNSON, CHRISTOPHER LINDSAY 1691 Final Rejection Jul 08, 2022
17789427 SOLID DOSAGE FORMS CONTAINING BACTERIA AND MICROBIAL EXTRACELLULAR VESICLES Evelo Biosciences, Inc. GHALI, ISIS A D 1611 Non-Final OA Jun 27, 2022
17787007 ALUMINOSILICATE GLASS Macquarie University FORSYTH, PAUL ALAN 1731 Final Rejection Jun 24, 2022
17781467 COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION Intocell, Inc. CHANDRAKUMAR, NIZAL S 1625 Final Rejection Jun 01, 2022
17780819 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA Evelo Biosciences, Inc. EIX, EMILY FAY 1653 Final Rejection May 27, 2022
17779002 METHODS OF TREATING CANCER USING DKK-1 INHIBITORS Leap Therapeutics, Inc. SULLIVAN, DENNIS JOHN 1642 Non-Final OA May 23, 2022
17776424 CHARACTERIZING MODULATORS OF ADAMTS-7 AND ADAMTS-12 BAYER AKTIENGESELLSCHAFT KAPUSHOC, STEPHEN THOMAS 1683 Non-Final OA May 12, 2022
17743178 PATIENT-SPECIFIC COMPUTATIONAL SIMULATION OF CORONARY ARTERY BYPASS GRAFTING BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA FERNANDEZ, KATHERINE L 3798 Non-Final OA May 12, 2022
17776068 BEAD SYSTEMS, METHODS, AND APPARATUS FOR MAGNETIC BEAD-BASED ANALYTE DETECTION Quantum Diamond Technologies Inc. MARCSISIN, ELLEN JEAN 1677 Final Rejection May 11, 2022
17723828 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS Gnt Pharma Co., Ltd. TRAN, ERIC 1629 Final Rejection Apr 19, 2022
17768778 NON-CODING RNA PROTECTING AGAINST HEART FAILURE Medizinische Hochschule Hannover MARVICH, MARIA 1634 Final Rejection Apr 13, 2022
17767791 MULTI-DOMAIN PROTEIN VACCINE Dionis Therapeutics, Inc. MARTIN, RACHEL E 1657 Non-Final OA Apr 08, 2022
17767798 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. SZNAIDMAN, MARCOS L 1628 Non-Final OA Apr 08, 2022
17764043 ENHANCING CANCER THERAPY TREATMENT WITH BH3 MIMETICS The Regents of the University of Colorado LU, CHENG 1642 Final Rejection Mar 25, 2022
17761946 USE OF DKK-1 INHIBITORS FOR TREATING CANCER Leap Therapeutics, Inc. LU, CHENG 1642 Non-Final OA Mar 18, 2022
17692108 SIMULTANEOUS MULTIPLEX GENOME EDITING IN YEAST Inscripta, Inc. LEITH, NANCY J 1636 Non-Final OA Mar 10, 2022
17633693 COMPOUNDS AND COMPOSITIONS FOR DIFFERENTIAL MODULATION OF NICOTINAMIDE ADENINE DINUCLEOTIDE Metro International Biotech, LLC BRANDSEN, BENJAMIN MICHAEL 1693 Non-Final OA Feb 08, 2022
17632449 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA Evelo Biosciences, Inc. SHAHNAN SHAH, KHATOL S 1645 Final Rejection Feb 02, 2022
17630692 DOSING REGIMENS FOR ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. SIMMONS, CHRIS E 1622 Final Rejection Jan 27, 2022
17566927 DISTRIBUTED DATA GATHERING AND RECOMMENDATION IN PHYTOTHERAPY Michael S. Clemmons NAULT, VICTOR ADELARD 2124 Non-Final OA Dec 31, 2021
17553299 LIPOSOMAL PREPARATIONS FOR NON-INVASIVE-PRENATAL OR CANCER SCREENING Seracare Life Sciences, Inc. JOHANNSEN, DIANA B 1682 Final Rejection Dec 16, 2021
16964965 ANTIBODY-DRUG CONJUGATES THAT TARGET DLK1 AND USES THEREOF Y-Biologics, Inc. PUTTLITZ, KARL J 1646 Non-Final OA Nov 30, 2021
17613341 METHODS AND COMPOSITIONS FOR ANAEROBIC BACTERIAL FERMENTATION Evelo Biosciences, Inc. MOAZZAMI, NAGHMEH NINA 1652 Non-Final OA Nov 22, 2021
17612972 KRAS G12C INHIBITORS AND USES THEREOF The Regents of the University of California MOU, LIYUAN 1628 Final Rejection Nov 19, 2021
17610198 Methods of Treating Cancer Using CHK1 Inhibitors Crt Pioneer Fund LP BAUER, NICOLA MARIA 1621 Non-Final OA Nov 10, 2021
17603707 THERAPEUTIC COMBINATIONS, LIQUID PHARMACEUTICAL COMPOSITIONS, KITS FOR THEIR PREPARATION, AND METHODS OF THEIR USE Prevep, Inc. DONOGHUE, BRITTNEY ERIN 1675 Final Rejection Oct 14, 2021
17602076 Enhancement of Melanocyte Migration Using ROCK Inhibitors The General Hospital Corporation MCKILLOP, JOHN CHARLES 1637 Non-Final OA Oct 07, 2021
17601383 MANUFACTURING ANTI-BCMA CAR T CELLS 2Seventy Bio, Inc. ABUZEINEH, HANAN ISAM 1633 Non-Final OA Oct 04, 2021
17482579 TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT Advantage Therapeutics, Inc. TIEN, LUCY MINYU 1612 Non-Final OA Sep 23, 2021
17464315 METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS VIA CELL CYCLE SYNCHRONIZATION Sapphiros Al Bio LLC ABUZEINEH, HANAN ISAM 1633 Final Rejection Sep 01, 2021
17390096 ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES Boyce Thompson Institute For Plant Research MILLER, DALE R 1693 Non-Final OA Jul 30, 2021
17352493 INTEGRATED IMAGING AND MEDICAL DEVICE DELIVERY APPARATUS AND METHOD OF USE VASCUTEK LIMITED PEHLKE, CAROLYN A 3799 Final Rejection Jun 21, 2021
17311610 SYSTEM AND METHOD FOR ACHIEVING HIGH GENE DATA RESOLUTION USING TRAINING SETS Ada Forsyth Institute, Inc. ZHANG, KAIJIANG 1684 Non-Final OA Jun 07, 2021
17324366 OFFER SELECTION OPTIMIZATION FOR PERSONA SEGMENTS Punchh Inc. MPAMUGO, CHINYERE 3685 Final Rejection May 19, 2021
17282336 PEPTIDE IMMUNOGEN CONSTRUCTS DIRECTED AGAINST DIPEPTIDE REPEAT PROTEINS FROM C9ORF72 UNS IP HOLDINGS, LLC BALLARD, KIMBERLY 1675 Non-Final OA Apr 01, 2021
17057432 METHODS TO IDENTIFY STRUCTURAL VARIATIONS THAT CAUSE DISEASES AND THE REGIONS TO REPAIR WITH GENE EDITING Williwaw Biosciences LLC PULLIAM, JOSEPH CONSTANTINE 1687 Final Rejection Nov 20, 2020
17057060 CHIMERIC ANTIGEN RECEPTORS WITH MODIFIED LINKER DOMAINS AND USES THEREOF BIOSCEPTRE (AUST) PTY LTD MIDDLETON, DANAYA L 1674 Non-Final OA Nov 19, 2020
17053422 STEM CELL-DERIVED CELL CULTURES, STEM CELL-DERIVED THREE DIMENSIONAL TISSUE PRODUCTS, AND METHODS OF MAKING AND USING THE SAME The Regents of the University of Colorado CORDAS, EMILY ANN 1632 Non-Final OA Nov 06, 2020
17089448 Diagnostic Method Amazentis SA FRITCHMAN, REBECCA M 1758 Final Rejection Nov 04, 2020
16978362 IPSC-DERIVED CELL COMPOSITIONS, AND RELATED SYSTEMS AND METHODS FOR CARTILAGE REPAIR Orig3N, Inc. MOSS, NATALIE M 1653 Non-Final OA Sep 04, 2020
16960767 SYSTEMS AND METHODS FOR DISTRIBUTING CELL THERAPIES Atara Biotherapeutics, Inc. PULLIAM, JOSEPH CONSTANTINE 1687 Non-Final OA Jul 08, 2020
16741594 ENCODING TEXTUAL DATA FOR PERSONALIZED INVENTORY MANAGEMENT Punchh Inc. RAMPHAL, LATASHA DEVI 3688 Final Rejection Jan 13, 2020
16623205 PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND FORMULATIONS THEREOF FOR TREATMENT OF SYNUCLEINOPATHIES UNS IP HOLDINGS, LLC BUCKMASTER, MARLENE VRENI 1672 Final Rejection Dec 16, 2019
16490419 DEVICES, METHODS, AND COMPOSITIONS USEFUL IN CRYO-PRESERVATION, -STORAGE, -TRANSPORT, AND APPLICATION OF THERAPEUTIC MAMMALIAN CELLS Discgenics, Inc. ABEL, LENORA A 1799 Final Rejection Aug 30, 2019
16423344 Portable Drug Mixing and Delivery Device and Associated Methods Windgap Medical, Inc. SCHMIDT, EMILY LOUISE 3783 Final Rejection May 28, 2019
15738954 COMPOSITIONS AND METHODS RELATED TO SCAVENGER PARTICLES Nanotics, LLC PALENIK, JEFFREY T 1615 Final Rejection Dec 21, 2017

Managing Foley Hoag, LLP (General)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month